MTOR and central nervous system cancer: The present study demonstrated that NPS‐2143 showed the strongest anti‐glioma ability among 50 candidate compounds, and NPS‐2143 could inhibit the growth and invasion, induced cell cycle arrest and apoptosis of glioma by suppressing autophagy through mediating the AKT–mTOR pathway.